Medline Inc. L10
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.68B | 29.94B | 29.14B | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.68B | 29.94B | 29.14B | -- | -- |
| Cost of Revenue | 23.19B | 22.43B | 21.61B | -- | -- |
| Gross Profit | 7.49B | 7.51B | 7.54B | -- | -- |
| SG&A Expenses | 5.05B | 4.90B | 4.70B | -- | -- |
| Depreciation & Amortization | 705.00M | 706.00M | 705.00M | -- | -- |
| Other Operating Expenses | 67.00M | 65.00M | 67.00M | -- | -- |
| Total Operating Expenses | 29.01B | 28.10B | 27.07B | -- | -- |
| Operating Income | 1.67B | 1.84B | 2.07B | -- | -- |
| Income Before Tax | 1.12B | 1.08B | 1.20B | -- | -- |
| Income Tax Expenses | 242.00M | 197.00M | 127.00M | -- | -- |
| Earnings from Continuing Operations | 876.00 | 880.00 | 1.07K | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -310.00M | -187.00M | -108.00M | -- | -- |
| Net Income | 566.00M | 693.00M | 966.00M | -- | -- |
| EBIT | 1.67B | 1.84B | 2.07B | -- | -- |
| EBITDA | 2.70B | 2.86B | 3.09B | -- | -- |
| EPS Basic | 0.68 | 0.48 | 0.43 | -- | -- |
| Normalized Basic EPS | 0.46 | 0.40 | 0.33 | -- | -- |
| EPS Diluted | 0.67 | 0.47 | 0.42 | -- | -- |
| Normalized Diluted EPS | 0.43 | 0.40 | 0.33 | -- | -- |
| Average Basic Shares Outstanding | 3.36B | 19.97B | 36.61B | -- | -- |
| Average Diluted Shares Outstanding | 3.81B | 19.98B | 36.62B | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 16.96% | 31.02% | 53.62% | -- | -- |